Glucose degradation products in peritoneal dialysis fluids: Do they harm?

Janusz Witowski, Achim Jörres, Katarzyna Korybalska, Krzysztof Ksiazek, Justyna Wisniewska-Elnur, Thorsten O. Bender, Jutta Passlick-Deetjen, Andrzej Breborowicz

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background. Severe limitations in biocompatibility of conventional peritoneal dialysis fluids (PDF) can be partially attributed to the presence of glucose degradation products (GDP), which are generated during autoclaving of PDF. Formation of GDP can be significantly reduced by the use of multi-chamber bag systems. Recent clinical studies have revealed increased dialysate levels of pro-collagen I C-terminal peptide (PICP) in patients dialyzed with these solutions. Here, we briefly review the current knowledge on various aspects of GDP toxicity toward peritoneal cells and analyze the impact of GDP on PICP release by human peritoneal mesothelial cells (HPMC) in vitro. Methods. HPMC were exposed to a mixture of known GDP added to culture medium at clinically relevant doses. After 12 days, the amount of PICP released was measured using an immunoassay. Furthermore, the protein synthesis was assessed by 3H-proline incorporation in HPMC exposed to peritoneal effluent obtained from patients after three months of CAPD with either conventional PDF or low-GDP solution. Results. Exposure to GDP resulted in a significant decrease in PICP release by HPMC. In addition, the synthesis of new proteins secreted by HPMC was preserved significantly better in HPMC treated with effluent obtained when patients were dialyzed with low-GDP solutions rather than conventional PDF. Conclusions. Exposure to GDP may impair protein synthesis and secretion by HPMC. Therefore, increased dialysate PICP levels in response to GDP-free PDF may be viewed as evidence of improved mesothelial cell function.

Original languageEnglish (US)
JournalKidney International, Supplement
Volume63
Issue number84
StatePublished - May 2003
Externally publishedYes

Fingerprint

Ascitic Fluid
Peritoneal Dialysis
Glucose
Collagen
Peptides
Dialysis Solutions
Proteins
Continuous Ambulatory Peritoneal Dialysis
Immunoassay
Proline
Culture Media

Keywords

  • Biocompatibility
  • Glucose degradation products
  • Peritoneal dialysis fluids
  • Peritoneal mesothelial cells

ASJC Scopus subject areas

  • Nephrology

Cite this

Witowski, J., Jörres, A., Korybalska, K., Ksiazek, K., Wisniewska-Elnur, J., Bender, T. O., ... Breborowicz, A. (2003). Glucose degradation products in peritoneal dialysis fluids: Do they harm? Kidney International, Supplement, 63(84).

Glucose degradation products in peritoneal dialysis fluids : Do they harm? / Witowski, Janusz; Jörres, Achim; Korybalska, Katarzyna; Ksiazek, Krzysztof; Wisniewska-Elnur, Justyna; Bender, Thorsten O.; Passlick-Deetjen, Jutta; Breborowicz, Andrzej.

In: Kidney International, Supplement, Vol. 63, No. 84, 05.2003.

Research output: Contribution to journalArticle

Witowski, J, Jörres, A, Korybalska, K, Ksiazek, K, Wisniewska-Elnur, J, Bender, TO, Passlick-Deetjen, J & Breborowicz, A 2003, 'Glucose degradation products in peritoneal dialysis fluids: Do they harm?', Kidney International, Supplement, vol. 63, no. 84.
Witowski J, Jörres A, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Bender TO et al. Glucose degradation products in peritoneal dialysis fluids: Do they harm? Kidney International, Supplement. 2003 May;63(84).
Witowski, Janusz ; Jörres, Achim ; Korybalska, Katarzyna ; Ksiazek, Krzysztof ; Wisniewska-Elnur, Justyna ; Bender, Thorsten O. ; Passlick-Deetjen, Jutta ; Breborowicz, Andrzej. / Glucose degradation products in peritoneal dialysis fluids : Do they harm?. In: Kidney International, Supplement. 2003 ; Vol. 63, No. 84.
@article{3a0d41a9e5fa4e72906d84fde1651017,
title = "Glucose degradation products in peritoneal dialysis fluids: Do they harm?",
abstract = "Background. Severe limitations in biocompatibility of conventional peritoneal dialysis fluids (PDF) can be partially attributed to the presence of glucose degradation products (GDP), which are generated during autoclaving of PDF. Formation of GDP can be significantly reduced by the use of multi-chamber bag systems. Recent clinical studies have revealed increased dialysate levels of pro-collagen I C-terminal peptide (PICP) in patients dialyzed with these solutions. Here, we briefly review the current knowledge on various aspects of GDP toxicity toward peritoneal cells and analyze the impact of GDP on PICP release by human peritoneal mesothelial cells (HPMC) in vitro. Methods. HPMC were exposed to a mixture of known GDP added to culture medium at clinically relevant doses. After 12 days, the amount of PICP released was measured using an immunoassay. Furthermore, the protein synthesis was assessed by 3H-proline incorporation in HPMC exposed to peritoneal effluent obtained from patients after three months of CAPD with either conventional PDF or low-GDP solution. Results. Exposure to GDP resulted in a significant decrease in PICP release by HPMC. In addition, the synthesis of new proteins secreted by HPMC was preserved significantly better in HPMC treated with effluent obtained when patients were dialyzed with low-GDP solutions rather than conventional PDF. Conclusions. Exposure to GDP may impair protein synthesis and secretion by HPMC. Therefore, increased dialysate PICP levels in response to GDP-free PDF may be viewed as evidence of improved mesothelial cell function.",
keywords = "Biocompatibility, Glucose degradation products, Peritoneal dialysis fluids, Peritoneal mesothelial cells",
author = "Janusz Witowski and Achim J{\"o}rres and Katarzyna Korybalska and Krzysztof Ksiazek and Justyna Wisniewska-Elnur and Bender, {Thorsten O.} and Jutta Passlick-Deetjen and Andrzej Breborowicz",
year = "2003",
month = "5",
language = "English (US)",
volume = "63",
journal = "Kidney International, Supplement",
issn = "0098-6577",
publisher = "Wiley-Blackwell",
number = "84",

}

TY - JOUR

T1 - Glucose degradation products in peritoneal dialysis fluids

T2 - Do they harm?

AU - Witowski, Janusz

AU - Jörres, Achim

AU - Korybalska, Katarzyna

AU - Ksiazek, Krzysztof

AU - Wisniewska-Elnur, Justyna

AU - Bender, Thorsten O.

AU - Passlick-Deetjen, Jutta

AU - Breborowicz, Andrzej

PY - 2003/5

Y1 - 2003/5

N2 - Background. Severe limitations in biocompatibility of conventional peritoneal dialysis fluids (PDF) can be partially attributed to the presence of glucose degradation products (GDP), which are generated during autoclaving of PDF. Formation of GDP can be significantly reduced by the use of multi-chamber bag systems. Recent clinical studies have revealed increased dialysate levels of pro-collagen I C-terminal peptide (PICP) in patients dialyzed with these solutions. Here, we briefly review the current knowledge on various aspects of GDP toxicity toward peritoneal cells and analyze the impact of GDP on PICP release by human peritoneal mesothelial cells (HPMC) in vitro. Methods. HPMC were exposed to a mixture of known GDP added to culture medium at clinically relevant doses. After 12 days, the amount of PICP released was measured using an immunoassay. Furthermore, the protein synthesis was assessed by 3H-proline incorporation in HPMC exposed to peritoneal effluent obtained from patients after three months of CAPD with either conventional PDF or low-GDP solution. Results. Exposure to GDP resulted in a significant decrease in PICP release by HPMC. In addition, the synthesis of new proteins secreted by HPMC was preserved significantly better in HPMC treated with effluent obtained when patients were dialyzed with low-GDP solutions rather than conventional PDF. Conclusions. Exposure to GDP may impair protein synthesis and secretion by HPMC. Therefore, increased dialysate PICP levels in response to GDP-free PDF may be viewed as evidence of improved mesothelial cell function.

AB - Background. Severe limitations in biocompatibility of conventional peritoneal dialysis fluids (PDF) can be partially attributed to the presence of glucose degradation products (GDP), which are generated during autoclaving of PDF. Formation of GDP can be significantly reduced by the use of multi-chamber bag systems. Recent clinical studies have revealed increased dialysate levels of pro-collagen I C-terminal peptide (PICP) in patients dialyzed with these solutions. Here, we briefly review the current knowledge on various aspects of GDP toxicity toward peritoneal cells and analyze the impact of GDP on PICP release by human peritoneal mesothelial cells (HPMC) in vitro. Methods. HPMC were exposed to a mixture of known GDP added to culture medium at clinically relevant doses. After 12 days, the amount of PICP released was measured using an immunoassay. Furthermore, the protein synthesis was assessed by 3H-proline incorporation in HPMC exposed to peritoneal effluent obtained from patients after three months of CAPD with either conventional PDF or low-GDP solution. Results. Exposure to GDP resulted in a significant decrease in PICP release by HPMC. In addition, the synthesis of new proteins secreted by HPMC was preserved significantly better in HPMC treated with effluent obtained when patients were dialyzed with low-GDP solutions rather than conventional PDF. Conclusions. Exposure to GDP may impair protein synthesis and secretion by HPMC. Therefore, increased dialysate PICP levels in response to GDP-free PDF may be viewed as evidence of improved mesothelial cell function.

KW - Biocompatibility

KW - Glucose degradation products

KW - Peritoneal dialysis fluids

KW - Peritoneal mesothelial cells

UR - http://www.scopus.com/inward/record.url?scp=0242500833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242500833&partnerID=8YFLogxK

M3 - Article

C2 - 12694333

AN - SCOPUS:0242500833

VL - 63

JO - Kidney International, Supplement

JF - Kidney International, Supplement

SN - 0098-6577

IS - 84

ER -